BLG 699 Chapter Notes - Chapter 12: Fair Division, Minimax, The Exploited
Document Summary
How to do research fairly in an unjust world by angela j. ballantyne. Debates on international research focused on preventing exploitation by providing fair benefits for subjects. One of the distinctive features of outsourced biomedical resarch is its role in providing access to basic healthcare for underserved populations. Appropriate normative standard of fairness for international resaerch must provide guidance for transactions involving distribution of basic goods. I(cid:374)te(cid:396)(cid:374)atio(cid:374)al (cid:396)esea(cid:396)(cid:272)h is (cid:271)io(cid:373)edi(cid:272)al (cid:396)esea(cid:396)(cid:272)h that(cid:859)s (cid:272)a(cid:396)(cid:396)ied out o(cid:374) populatio(cid:374)(cid:894)s(cid:895) i(cid:374) middle- or low-income countries and sponsored by a foreign entity. There are three categories of sponsors of global health research: private-for-profit (48%, public (45%, private-not-profit (7%) For-profit research is funded by pharmaceutical companies and is increasingly carried out by contract research organizations (cros) Guidelines for international research issued by organizations required that research in developing countries address a health priority of the host community: this is intended to limit use of patients solely for the benefit.